Frontier, Biotech

Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics

Published on 03/19/2026 at 10:46 | prnewswire.co.uk

Frontier Biotechnologies Inc. New York China

en | CH0038389992 | FRONTIER | boerse | 68852716 |